Fungi and Protozoa — Current Affairs 2026
Current Affairs Connections
WHO's 'High Burden to High Impact' Strategy and New Malaria Vaccine Rollout
2023-2024The World Health Organization (WHO) continues to push its 'High Burden to High Impact' strategy, aiming for significant reductions in malaria cases and deaths. A major development is the expanded rollout of the RTS,S/AS01 malaria vaccine and the recent prequalification of the R21/Matrix-M vaccine, marking a new era in malaria prevention. These efforts are crucial for countries like India, which is part of the NVBDCP updates, as it grapples with a substantial malaria burden, particularly from *Plasmodium vivax*. The exam-smart approach is to connect these global health initiatives with India's specific challenges and progress in disease control.
UPSC Angle: Impact of global health initiatives on India's public health, vaccine development and deployment challenges, strategies for vector-borne disease control, and the role of international organizations like WHO in disease elimination.
Surge in COVID-19 Associated Fungal Infections (CAFI) and Antifungal Resistance Concerns
2020-2022 (with ongoing implications)The COVID-19 pandemic led to a dramatic increase in opportunistic fungal infections, most notably mucormycosis (black fungus) and invasive aspergillosis, particularly in patients with severe COVID-19, diabetes, or those receiving immunosuppressive therapies. This surge highlighted the vulnerability of immunocompromised individuals and underscored the growing challenge of antifungal resistance. New antifungal approvals are critical in this context, as existing drugs face increasing resistance. This event brought fungal diseases UPSC notes into sharp focus for public health preparedness.
UPSC Angle: Opportunistic infections in immunocompromised states, challenges in managing co-infections, the emergence of drug resistance in fungi, public health preparedness for pandemics, and the role of environmental factors in disease outbreaks.